Reau N - Search Results

1

Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journals.

Malhi H, Brown RS Jr, Lim JK, Reau N, Tapper EB, Wong CC, Gores GJ. Malhi H, et al. Among authors: reau n. Clin Liver Dis (Hoboken). 2023 Nov 9;22(6):193-194. doi: 10.1097/CLD.0000000000000094. eCollection 2023 Dec. Clin Liver Dis (Hoboken). 2023. PMID: 38143807 Free PMC article. No abstract available.

2

Corrigendum: Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir With or Without Ribavirin in HCV-Infected Patients Taking Concomitant Acid-Reducing Agents.

Shiffman ML, Rustgi V, Bennett M, Forns X, Asselah T, Vila RP, Liu L, Pedrosa M, Moller J, Reau N. Shiffman ML, et al. Among authors: reau n. Am J Gastroenterol. 2016 Jul;111(7):1077. doi: 10.1038/ajg.2016.202. Am J Gastroenterol. 2016. PMID: 27356843 Free PMC article. No abstract available.

3

Abdominal pain in a woman with cancer.

Reau NS, Young JJ, Mazzaferri EL. Reau NS, et al. Hosp Pract (1995). 1999 Oct 15;34(11):129-32. doi: 10.1080/21548331.1999.11443934. Hosp Pract (1995). 1999. PMID: 10887437 No abstract available.

4

Concomitant proton pump inhibitor use does not reduce the efficacy of elbasvir/grazoprevir: A pooled analysis of 1,322 patients with hepatitis C infection.

Reau N, Robertson MN, Feng HP, Caro L, Yeh WW, Nguyen BT, Wahl J, Barr E, Hwang P, Klopfer SO. Reau N, et al. Hepatol Commun. 2017 Aug 22;1(8):757-764. doi: 10.1002/hep4.1081. eCollection 2017 Oct. Hepatol Commun. 2017. PMID: 29404492 Free PMC article.

5

Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases.

Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS; American Association for the Study of Liver Diseases. Bacon BR, et al. Hepatology. 2011 Jul;54(1):328-43. doi: 10.1002/hep.24330. Hepatology. 2011. PMID: 21452290 Free PMC article. No abstract available.

6

Potential consequences of healthcare recommendations: a focus on the U.S. Preventive Services Task Force.

Satoskar R, Reau N. Satoskar R, et al. Among authors: reau n. Hepatology. 2013 Jul;58(1):422-7. doi: 10.1002/hep.26349. Epub 2013 May 27. Hepatology. 2013. PMID: 23460345

7

Screening for Zinc Deficiency in Patients with Cirrhosis: When Should We Start?

Sengupta S, Wroblewski K, Aronsohn A, Reau N, Reddy KG, Jensen D, Te H. Sengupta S, et al. Among authors: reau n. Dig Dis Sci. 2015 Oct;60(10):3130-5. doi: 10.1007/s10620-015-3613-0. Epub 2015 Mar 6. Dig Dis Sci. 2015. PMID: 25742912

8

Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 1.

Zeuzem S, Sulkowski MS, Lawitz EJ, Rustgi VK, Rodriguez-Torres M, Bacon BR, Grigorescu M, Tice AD, Lurie Y, Cianciara J, Muir AJ, Cronin PW, Pulkstenis E, Subramanian GM, McHutchison JG; ACHIEVE-1 Study Team. Zeuzem S, et al. Gastroenterology. 2010 Oct;139(4):1257-66. doi: 10.1053/j.gastro.2010.06.066. Epub 2010 Jun 27. Gastroenterology. 2010. PMID: 20600013 Clinical Trial.

9

Evaluation of early null response to pegylated interferon and ribavirin as a predictor of therapeutic nonresponse in patients undergoing treatment for chronic hepatitis C.

Reau N, Satoskar R, Te H, DeVoss A, Elsen C, Reddy G, Mohanty S, Jensen D. Reau N, et al. Am J Gastroenterol. 2011 Mar;106(3):452-8. doi: 10.1038/ajg.2010.424. Epub 2010 Nov 9. Am J Gastroenterol. 2011. PMID: 21063395

10

Corrigendum: ACG Clinical Guideline: Liver Disease and Pregnancy.

Tran TT, Ahn J, Reau NS. Tran TT, et al. Am J Gastroenterol. 2016 Nov;111(11):1668. doi: 10.1038/ajg.2016.462. Am J Gastroenterol. 2016. PMID: 27808138 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

118 results

Search Page